Retinal vein occlusion. A comparative study of factors affecting the prognosis, including a therapeutic trial of Atromid S in this condition.
D000328:Adult; D000367:Age Factors; D000368:Aged; D000738:Androsterone / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001794:Blood Pressure; D001798:Blood Proteins / Q000032:analysis; D002087:Butyrates / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000150:complications; D003327:Coronary Disease / Q000150:complications; D004562:Electrocardiography; D005260:Female; D005654:Fundus Oculi; D006349:Heart Valve Diseases / Q000150:complications; D006801:Humans; D007429:Intraocular Pressure; D008297:Male; D008875:Middle Aged; D009884:Ophthalmodynamometry; D010919:Placebos; D011379:Prognosis; D013902:Radiography, Thoracic; D012171:Retinal Vessels; D012737:Sex Factors; D014652:Vascular Diseases / Q000188:drug therapy; D014680:Veins; D014794:Visual Fields
D000924:Anticholesteremic Agents; D001798:Blood Proteins; D002087:Butyrates; D010919:Placebos; D000738:Androsterone